Biopharmaceuticals
Litigation
Licensing
News Release - May 14, 2019
AbbVie Resolves HUMIRA(R) (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
Source: AbbVie
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.